Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
Indo Tambangraya Megah Tbk PT
OTC:ITAYY
|
ID |
|
Equity Commonwealth
NYSE:EQC
|
US |
|
Forza Petroleum Ltd
TSX:FORZ
|
CA |
|
J
|
Jiangxi Tianli Technology INC
SZSE:300399
|
CN |
Balance Sheet
Balance Sheet Decomposition
Mink Therapeutics Inc
Mink Therapeutics Inc
Balance Sheet
Mink Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
3
|
39
|
20
|
3
|
5
|
|
| Cash Equivalents |
0
|
3
|
39
|
20
|
3
|
5
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
1
|
4
|
40
|
20
|
4
|
5
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
1
N/A
|
5
+248%
|
40
+782%
|
21
-47%
|
5
-79%
|
6
+26%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
3
|
3
|
6
|
4
|
3
|
|
| Accrued Liabilities |
3
|
2
|
2
|
4
|
5
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
10
|
12
|
3
|
2
|
2
|
|
| Total Current Liabilities |
7
|
14
|
16
|
13
|
11
|
7
|
|
| Long-Term Debt |
27
|
44
|
0
|
0
|
0
|
5
|
|
| Other Liabilities |
3
|
0
|
0
|
9
|
11
|
13
|
|
| Total Liabilities |
38
N/A
|
58
+55%
|
16
-72%
|
22
+33%
|
23
+3%
|
25
+12%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
37
|
53
|
83
|
111
|
133
|
144
|
|
| Additional Paid In Capital |
0
|
0
|
107
|
111
|
116
|
125
|
|
| Other Equity |
0
|
2
|
1
|
0
|
0
|
1
|
|
| Total Equity |
36
N/A
|
54
-48%
|
24
N/A
|
0
N/A
|
18
-4 414%
|
20
-8%
|
|
| Total Liabilities & Equity |
1
N/A
|
5
+248%
|
40
+782%
|
21
-47%
|
5
-79%
|
6
+26%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
1
|
1
|
3
|
3
|
3
|
4
|
|